Congress and the Extra Seminars Program

Download the IATDMCT 2021 detailed program here!
Last update: September 22th


You can also see the interactive agenda online here or by downloading our app!

Click the button below to see the IATDMCT 2021 program at a glance.
Last update: September 17th


Pharmacometrics-enhanced TDM (CME)

The International Congress of Therapeutic Drug Monitoring & Clinical Toxicology (IATDMCT), the most focused on the individual patient Society, has identified the need to teach clinically meaningful quantitative methods such as PK and the decision theory to improve our understanding and control of drug therapy.
To this end, the following program is proposed for a Pre-Congress Seminar which will take place on September 19th in Rome on the occasion of the 19th IATDMCT Congress (September 19th-22nd 2021)

It consists of two parts:

  • the first covering basic pharmacometrics modelling;
  • the second precision dosing and clinical trial optimisation.

Each part starts with introductory lectures, after which ample time is reserved for participants to get their hands dirty on the subject, using prepared scripts and models, under the guidance of the Scientific Committee members.

Pharmacometrics-enhanced TDM

TDM in pediatric patients as well as in neonates (CME)

Therapeutic Drug Monitoring (TDM) is the result of a multidisciplinary teamwork that involves professional figures with different expertise. Application of TDM to the routine clinical practice becomes particularly important in a pediatric and neonatal setting where patients are characterized by physiological and pathological changes that makes drug pharmacokinetic behaviour unpredictable and therefore responses to therapy uncertain. In fact, it has been estimated that almost 30-40 % of pediatric patients affected by haematological disorders or immunocompromised or subjected to invasive procedures such as dialysis or ECMO, or hospitalized into intensive care units, has experienced a therapeutic failure and/or adverse drug reactions. Therefore, the aim of this pre-congress seminar is to highlight the importance of TDM applied to routine clinical practice and its utility in pediatric and neonatal real-life experiences.

TDM in pediatric patients as well as in neonates

The pre-congresses are included in all Congress fees. Participants not registered to the Congress who want to participate in the seminar can register to the pre-congress on the Registration form with the following fees:

PRE-CONFERENCE FEES* Early Regular On-site Criteria
IATDMCT MEMBERS Delegate standard € 100 € 130 € 150
Young Scientist/Junior € 90 € 120 € 150 Fee only for Young Scientists Members (31 – 40 years) and for Junior members (up to 30 years). Must provide proof of their age.
NON MEMBERS IATDMCT Delegate standard € 150 € 180 € 210

* the price displayed is intended for one pre-Congress seminar and is VAT included.

Three seminars organized on September 20th, 21st and 22nd.

The seminars on September 21st and 22nd are for Italian speakers only.

Pharmacometrics – Practical approaches to dose optimization (CME)


Fragile patient (Italian Seminar, ECM)

The application of TDM protocols returns significant improvements in the management of pharmacological therapies. These lead to the exploitation of the therapeutic benefit of drugs while sparing patients from toxicities. The control of the disease and the reduction of its severity are important in fragile patients to achieve a well-being state. The diagnosis of a chronic complex disease that naturally tends to worsen, likely associated with comorbidities, frequently requiring the administration of combined pharmacological therapies is a critical factor that makes the patient vulnerable. In the last decades, the increasing life expectancy (for example, thanks to the successful progresses in medicine) have increased the number of fragile patients, while the complexity of their characteristics has become more multifaceted. For these reasons, TDM has gained a growing role in patients’ management, a central topic in the IATDM-CT Congresses. Therefore, the present symposium will present and debate the need for personalized medicine in fragile patients starting from the clinicians’ perspective in two precise settings: the aged people and those who received a transplanted organ. In this manner, physicians will discuss their expectations, while the representatives and members of the IATDM-CT will collect those needs, discuss possible strategies and elaborate appropriate TDM plans. The symposium will widen the audience and disseminate the activities of the IATDM-CT members across Italian scientific societies.


TMD of monoclonal antibodies in rheumatology and gastroenterology (Italian Seminar, ECM)

Biotechnologies have increased the therapeutic armamentarium for severe diseases both in children and in adult patients. Monoclonal antibodies (mABs) received much attention in some therapeutic areas. Indeed, the chronic use of chemical drugs in rheumatology and gastroenterology may be associated with severe toxic effects. With the progressive prescription and administration of mABs, the demand for personalized medicine has become evident to counteract the variable pharmacokinetics among patients, control the disease and reduce the risk of toxicities. These needs strongly support the adoption of TDM protocols. However, some issues of mABs TDM are not yet completely solved. Indeed, some factors are still debated and require a critical discussion: the proactive and the reactive approaches, patients’ characteristics, the severity of the disease and the coadministration of immunomodulatory drugs. In addition to these, the availability of appropriate instrumental platforms represents another area of intense research and development. The coordinated efforts of physicians, pharmacologists and biochemists may overcome these issues. Speakers of the present symposium will introduce and discuss the medical needs and TDM opportunities while using the mABs, thus sharing contributes from representatives of IATDM-CT and Italian scientific societies.

Il Seminario è accreditato ai fini ECM per le seguenti figure professionali:

  • Biochimica di laboratorio
  • Laboratorio di analisi chimico clinica
  • Biologi
  • Medici di laboratori
  • Tecnici di laboratorio
  • Gastroenterologi
  • Reumatologi
  • Pediatri
  • Farmacologi
  • MMG

*The price displayed is intended for one intersocietal seminar and is VAT included.